Literature DB >> 9988688

Functional interaction of mammalian valyl-tRNA synthetase with elongation factor EF-1alpha in the complex with EF-1H.

B S Negrutskii1, V F Shalak, P Kerjan, A V El'skaya, M Mirande.   

Abstract

In mammalian cells valyl-tRNA synthetase (ValRS) forms a high Mr complex with the four subunits of elongation factor EF-1H. The beta, gamma, and delta subunits, that contribute the guanine nucleotide exchange activity of EF-1H, are tightly associated with the NH2-terminal polypeptide extension of valyl-tRNA synthetase. In this study, we have examined the possibility that the functioning of the companion enzyme EF-1alpha could regulate valyl-tRNA synthetase activity. We show here that the addition of EF-1alpha and GTP in excess in the aminoacylation mixture is accompanied by a 2-fold stimulation of valyl-tRNAVal synthesis catalyzed by the valyl-tRNA synthetase component of the ValRS.EF-1H complex. This effect is not observed in the presence of EF-1alpha and GDP or EF-Tu.GTP and requires association of valyl-tRNA synthetase within the ValRS.EF-1H complex. Since valyl-tRNA synthetase and elongation factor EF-1alpha catalyze two consecutive steps of the in vivo tRNA cycle, aminoacylation and formation of the ternary complex EF-1alpha.GTP. Val-tRNAVal that serves as a vector of tRNA from the synthetase to the ribosome, the data suggest a coordinate regulation of these two successive reactions. The EF-1alpha.GTP-dependent stimulation of valyl-tRNA synthetase activity provides further evidence for tRNA channeling during protein synthesis in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988688     DOI: 10.1074/jbc.274.8.4545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Decoding apparatus for eukaryotic selenocysteine insertion.

Authors:  R M Tujebajeva; P R Copeland; X M Xu; B A Carlson; J W Harney; D M Driscoll; D L Hatfield; M J Berry
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

2.  The intracellular location of two aminoacyl-tRNA synthetases depends on complex formation with Arc1p.

Authors:  K Galani; H Grosshans; K Deinert; E C Hurt; G Simos
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Looking for organization patterns of highly expressed genes: purine-pyrimidine composition of precursor mRNAs.

Authors:  A Paz; D Mester; E Nevo; A Korol
Journal:  J Mol Evol       Date:  2007-01-08       Impact factor: 2.395

4.  Two conformations of a crystalline human tRNA synthetase-tRNA complex: implications for protein synthesis.

Authors:  Xiang-Lei Yang; Francella J Otero; Karla L Ewalt; Jianming Liu; Manal A Swairjo; Caroline Köhrer; Uttam L RajBhandary; Robert J Skene; Duncan E McRee; Paul Schimmel
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

5.  Structural and functional mapping of the archaeal multi-aminoacyl-tRNA synthetase complex.

Authors:  Corinne D Hausmann; Michael Ibba
Journal:  FEBS Lett       Date:  2008-06-05       Impact factor: 4.124

Review 6.  Aminoacyl-tRNA synthetase complexes: molecular multitasking revealed.

Authors:  Corinne D Hausmann; Michael Ibba
Journal:  FEMS Microbiol Rev       Date:  2008-06-03       Impact factor: 16.408

Review 7.  Architecture and metamorphosis.

Authors:  Min Guo; Xiang-Lei Yang
Journal:  Top Curr Chem       Date:  2014

8.  Trypanothione S-transferase activity in a trypanosomatid ribosomal elongation factor 1B.

Authors:  Tim J Vickers; Alan H Fairlamb
Journal:  J Biol Chem       Date:  2004-04-08       Impact factor: 5.157

9.  A tryptophan-rich peptide acts as a transcription activation domain.

Authors:  Chen-Huan Lin; Grace Lin; Chia-Pei Chang; Chien-Chia Wang
Journal:  BMC Mol Biol       Date:  2010-11-16       Impact factor: 2.946

10.  Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells.

Authors:  Monika Kaminska; Svitlana Havrylenko; Paulette Decottignies; Pierre Le Maréchal; Boris Negrutskii; Marc Mirande
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.